Literature DB >> 20805913

Real-world Data on Atypical Antipsychotic Medication Side Effects.

Elisa Cascade1, Amir H Kalali, Sagar Mehra, Jonathan M Meyer.   

Abstract

In this article, we provide information on patient-reported side effects from a cross-section of real-world patients. Specifically, data on side effects were tabulated for patients taking at least one of the following atypical antipsychotic medications: aripiprazole, olanzapine, paliperidone, quetiapine, risperidone, or ziprasidone. Approximately 54 percent of the 353 respondents reported having experienced a side effect as a result of taking an atypical antipsychotic medication. Most common side effects mentioned included the following: weight gain/hunger, tiredness/lethargy, and lack of coordination/muscle problems, such as tenderness, twitches, and tremors. Of those experiencing a side effect, less than 25 percent reported this side effect to their physician.

Entities:  

Keywords:  Aripiprazole; atypical antipsychotic; olanzapine; paliperidone; quetiapine; risperidone; schizophrenia; self report; side effect; ziprasidone

Year:  2010        PMID: 20805913      PMCID: PMC2922368     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  7 in total

1.  From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase.

Authors:  Sangwon F Kim; Alex S Huang; Adele M Snowman; Cory Teuscher; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

2.  Distress with medication side effects among persons with severe mental illness.

Authors:  Nancy H Covell; Ellen M Weissman; Bonnie Schell; Brian H McCorkle; W Thomas Summerfelt; Peter J Weiden; Susan M Essock
Journal:  Adm Policy Ment Health       Date:  2007-09

3.  Which side effects really matter? Screening for common and distressing side effects of antipsychotic medications.

Authors:  P J Weiden; A L Miller
Journal:  J Psychiatr Pract       Date:  2001-01       Impact factor: 1.325

4.  H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

Authors:  Wesley K Kroeze; Sandra J Hufeisen; Beth A Popadak; Sean M Renock; SeAnna Steinberg; Paul Ernsberger; Karu Jayathilake; Herbert Y Meltzer; Bryan L Roth
Journal:  Neuropsychopharmacology       Date:  2003-03       Impact factor: 7.853

5.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

Authors:  Jeffrey A Lieberman; T Scott Stroup; Joseph P McEvoy; Marvin S Swartz; Robert A Rosenheck; Diana O Perkins; Richard S E Keefe; Sonia M Davis; Clarence E Davis; Barry D Lebowitz; Joanne Severe; John K Hsiao
Journal:  N Engl J Med       Date:  2005-09-19       Impact factor: 91.245

6.  Obesity as a risk factor for antipsychotic noncompliance.

Authors:  Peter J Weiden; Joan A Mackell; Diana D McDonnell
Journal:  Schizophr Res       Date:  2004-01-01       Impact factor: 4.939

7.  Obesity as a correlate of outcome in patients with bipolar I disorder.

Authors:  Andrea Fagiolini; David J Kupfer; Patricia R Houck; Danielle M Novick; Ellen Frank
Journal:  Am J Psychiatry       Date:  2003-01       Impact factor: 18.112

  7 in total
  3 in total

1.  Quality of life in patients with schizophrenia: the impact of socio-economic factors and adverse effects of atypical antipsychotics drugs.

Authors:  Aurigena Antunes de Araújo; Diego de Araújo Dantas; Gemma Galgani do Nascimento; Susana Barbosa Ribeiro; Katarina Melo Chaves; Vanessa de Lima Silva; Raimundo Fernandes de Araújo; Dyego Leandro Bezerra de Souza; Caroline Addison Carvalho Xavier de Medeiros
Journal:  Psychiatr Q       Date:  2014-09

2.  Antipsychotic Medications and DNA Methylation in Schizophrenia and Bipolar Disorder: A Systematic Review.

Authors:  Kyle J Burghardt; Audrey S Khoury; Zaher Msallaty; Zhengping Yi; Berhane Seyoum
Journal:  Pharmacotherapy       Date:  2020-03-09       Impact factor: 4.705

3.  Fluoxetine-induced alteration of murine gut microbial community structure: evidence for a microbial endocrinology-based mechanism of action responsible for fluoxetine-induced side effects.

Authors:  Mark Lyte; Stephan Schmitz-Esser; Karrie M Daniels
Journal:  PeerJ       Date:  2019-01-09       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.